CD2 and acute lymphoblastic leukemia: However, a subset of patients with T-cell ALL (exhibiting higher myeloid-like features) had miR-223 expression comparable to that in AML patients, higher than that in T-cell ALL patients and CD2+ cells from healthy donors [256].